Learn More
Medchemexpress LLC N-(2-(1H-indol-3-yl)ethyl)-5-(5-fluoropyridin-3-yl)-3-methylpyrazolo[1,5-a]pyrimidin-7-amine | 2247950-73-6 | 98.0% | 386.42 g/mol | C22H19FN6 | 5 MG

Supplier: Medchemexpress LLC HY1342175MG
KYN-101 is a potent, selective, orally active aryl hydrocarbon receptor (AHR) inhibitor used in research. It reduces CYP1A1 mRNA expression and has demonstrated anti-cancer activity in preclinical studies. Supplied as a small-quantity research compound with accompanying quality documentation.
- Potent, selective aryl hydrocarbon receptor (AHR) inhibitor.
- Orally active in preclinical models.
- Decreases CYP1A1 mRNA expression in cellular assays.
- Demonstrates anti-cancer activity in preclinical studies.
- Supplied as a small research quantity (e.g., 5 mg) with COA and datasheet.
- High purity (approximately 98.0%).
- For research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.